Michelle practices primarily in the fields of pharmaceuticals and biotechnology. She is involved in all areas of patent protection from identifying inventions and drafting patent applications to managing the prosecution to grant of worldwide patent portfolios. Michelle takes pride in providing clear and practical patent advice to clients as they bring their products to market.

She has a varied client base and has a wealth of experience in patents relating to pharmaceutical drugs, therapeutic antibodies and dosage forms.   She works with technologies in the field of DNA sequencing, antimicrobial therapies, combination therapies, retrovirals, chemistry, diagnostics and the protection of plants.

Michelle’s client portfolio includes a number of international pharmaceutical companies, as well as UK start-up companies and universities.

Michelle is a director and one of the founders of Harrison IP.